Delivery Order SPE2DB20D1004-SPE2DB23FF2S2
Award Date
2/16/23
Potential Completion Date
2/17/23
Potential Value
$3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGE to the Defense Logistics Agency (DLA). The $1,803.31 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 16, 2024 and was awarded on September 13, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This federal contract award is for the delivery of COSENTYX 300 mg dose-2 syringes to the Defense Logistics Agency (DLA). The contract, valued at $15,507.06, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type, and has an ultimate completion date of March 28, 2023. The contract is not set aside for any specific business type. AmerisourceBergen holds a...
This federal contract award is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGE medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,574.56 Firm Fixed Price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 26, 2025, with a completion date of February 27, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award is for the delivery of COSENTYX 300 MG DOSE-2 PEN, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $6,045.72 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, under an existing Indefinite Delivery Contract (IDC) valued at $999,999,999 with the DLA. This IDC serves as a primary vehicle for Amerisourcebergen to...
This federal contract award is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGE/ML pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $6,020.28 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 21, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...
This federal contract award is for the procurement of COSENTYX 150 MG/ML SYRINGEML, a pharmaceutical product, by the Defense Logistics Agency (DLA). The $5,174.31 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 29, 2024 and was not subject to any set-aside requirements. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
This federal contract award from the Defense Logistics Agency (DLA) is for the provision of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to support military healthcare programs. The $12,256.16 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
This federal contract award is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGE/ML to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $28,224.37 with a firm fixed price. The ultimate completion date is May 11, 2023. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,149.12 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024, with a completion date of November 27, 2024. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,574.56 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024 with a completion date of November 27, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...